Evidence map›Paper›PMID 39052682›Full record

ArticlePloS one2024

One-pot Golden Gate Assembly of an avian infectious bronchitis virus reverse genetics system.

Katharina Bilotti, Sarah Keep, Andrew P Sikkema, John M Pryor, James Kirk, Katalin Foldes, Nicole Doyle, Ge Wu, Graham Freimanis, Giulia Dowgier and 4 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katharina BilottiNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0003-2391-9645
Sarah KeepThe Pirbright Institute, Woking, United Kingdom.
Andrew P SikkemaNew England Biolabs, Ipswich, Massachusetts, United States of America.
John M PryorNew England Biolabs, Ipswich, Massachusetts, United States of America.
James KirkThe Pirbright Institute, Woking, United Kingdom.
Katalin FoldesThe Pirbright Institute, Woking, United Kingdom.
Nicole DoyleThe Pirbright Institute, Woking, United Kingdom.ORCID 0000-0002-6016-5830
Ge WuThe Pirbright Institute, Woking, United Kingdom.
Graham FreimanisThe Pirbright Institute, Woking, United Kingdom.
Giulia DowgierThe Francis Crick Institute, London, United Kingdom.
Oluwapelumi AdeyemiThe Pirbright Institute, Woking, United Kingdom.ORCID 0000-0002-0848-5917
S Kasra TabatabaeiNew England Biolabs, Ipswich, Massachusetts, United States of America.
Gregory J S LohmanNew England Biolabs, Ipswich, Massachusetts, United States of America.ORCID 0000-0002-0638-7555
Erica BickertonThe Pirbright Institute, Woking, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/H01425X/1Biotechnology and Biological Sciences Research Council BBS/E/I/00001424Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Biotechnology and Biological Sciences Research Council BBS/E/I/00007035Biotechnology and Biological Sciences Research Council BBS/E/I/00007037Biotechnology and Biological Sciences Research Council BBS/E/I/00007038Biotechnology and Biological Sciences Research Council BBS/E/I/00007039Biotechnology and Biological Sciences Research Council BBS/E/PI/230001BBiotechnology and Biological Sciences Research Council BBS/E/PI/230002ABiotechnology and Biological Sciences Research Council BBS/E/PI/23NB0003Biotechnology and Biological Sciences Research Council BBS/E/PI/23NB0004
6 · The paper itself

Abstract

Avian infectious bronchitis is an acute respiratory disease of poultry of particular concern for global food security. Investigation of infectious bronchitis virus (IBV), the causative agent of avian infectious bronchitis, via reverse genetics enables deeper understanding of virus biology and a rapid response to emerging variants. Classic methods of reverse genetics for IBV can be time consuming, rely on recombination for the introduction of mutations, and, depending on the system, can be subject to genome instability and unreliable success rates. In this study, we have applied data-optimized Golden Gate Assembly design to create a rapidly executable, flexible, and faithful reverse genetics system for IBV. The IBV genome was divided into 12 fragments at high-fidelity fusion site breakpoints. All fragments were synthetically produced and propagated in E. coli plasmids, amenable to standard molecular biology techniques for DNA manipulation. The assembly can be carried out in a single reaction, with the products used directly in subsequent viral rescue steps. We demonstrate the use of this system for generation of point mutants and gene replacements. This Golden Gate Assembly-based reverse genetics system will enable rapid response to emerging variants of IBV, particularly important to vaccine development for controlling spread within poultry populations.

Indexed as

Infectious bronchitis virusReverse GeneticsAnimalsCoronavirus InfectionsEscherichia coliGenome, ViralPlasmidsPoultry Diseases

Identifiers

PMID39052682
PMCPMC11271894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.